joe rogan on semaglutide When Joshua Hunt (@viajoshhunt) started Ozempic in April 2025, the weekly dose of the GLP-1 agonist transformed him. This past March, when he decided to stop, his cravings returned — for If you're on or considering
Description
Bone loss is preventable with the right habitslift weights, hit protein and micronutrient targets, and monitor progress with DXA
In the STEP UP trial, around 1 in 5 people on the higher dose reported skin sensitivity symptoms, compared with about 1 in 20 on the 2.4mg dose
The MTHFR enzyme breaks down homocysteine and folate in the body
Since the cost to manufacture GLP-1s is modest, higher utilization could lead to better health for the population and more profit for the pharmaceutical companies
